| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $15.7M | — | -8.5% |
| SG&A Expense | $6.6M | — | -60.1% |
| Operating Income | -$22.3M | — | +33.9% |
| Pre-tax Income | -$20.2M | — | +38.2% |
| Net Income | -$20.2M | — | +38.2% |
| EPS (Basic) | -$0.25 | — | +74.7% |
| EPS (Diluted) | -$0.25 | — | +74.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $71.8M | +13.9% | +148.2% |
| Current Assets | $200.9M | +6.6% | +90.8% |
| Total Assets | $250.4M | -6.8% | +99.2% |
| Current Liabilities | $14.2M | -15.6% | -54.0% |
| Total Liabilities | $18.9M | -14.4% | -49.8% |
| Stockholders' Equity | $231.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.1M | — | +2.6% |
| Capital Expenditures | $35K | — | — |
| Investing Cash Flow | $27.5M | — | +76.0% |
| Financing Cash Flow | $2.5M | — | — |
| Free Cash Flow | -$21.2M | — | — |
| +162.7% |